EMEA-001729-PIP01-14-M01

Key facts

Invented name
Active substance
Recombinant human nerve growth factor
Therapeutic area
Ophthalmology
Decision number
P/0280/2016
PIP number
EMEA-001729-PIP01-14-M01
Pharmaceutical form(s)
  • Eye drops
  • solution
Condition(s) / indication(s)
Treatment of neurotrophic keratitis
Route(s) of administration
Ocular use
Contact for public enquiries
Dompé farmaceutici SpA
Italy
Tel.: +39 3669018586
Email: lamberto.dionigi@dompe.com
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-001729-PIP01-14-M01
Compliance opinion date
10/11/2017
Compliance outcome
positive

Decision

How useful was this page?

Add your rating